
Giving Moms Latest Dietary Advice Cuts Infant Food Allergies
A recent Australian study in the Journal of Allergy and Clinical Immunology: In Practice confirmed that this strategy lowers the prevalence of immunoglobulin E (IgE) antibody-mediated egg, peanut, and cow's milk allergies but also stressed the critical importance of making sure parents get — and receive support in following — the latest dietary guidance on food allergy prevention.
The updated American Academy of Pediatrics guidance on food allergies supports the early introduction of potentially allergenic foods into infant diets.
Led by dietitian Debra Palmer, PhD, an associate professor and head of the Nutrition in Early Life team at The Kids Research Institute Australia in Nedlands, Western Australia, the study compared the prevalence of IgE-mediated food allergies at 1 year of age between two infant cohorts, before and after Australia's infant feeding and allergy prevention guidelines of 2016.
'The immediate trigger for the study was the unexpectedly low rate of food allergies observed in a recent high-risk infant cohort, prompting investigation into whether the provision and explanation of the updated guidelines to families played a role,' study co-author Summer Walker, BSc, a PhD candidate at the institute, told Medscape Medical News . 'With existing longitudinal data from before and after the guideline change, the team was well-positioned to compare cohorts and provide valuable real-world evidence bridging clinical trial results and public health practice.'
The Study
The babies, at high familial risk for allergies, were born to mothers in Perth, Western Australia. All babies had a first-degree relative with a history of allergic disease: food, skin, or respiratory.
In cohort 1 (n = 506, born 2006-2014), no feeding advice was provided to participants. In cohort 2 (n = 566, born 2016-2022), all families were provided with updated infant feeding and allergy prevention guidelines. when the infants were 6 months of age.
By 12 months of age, 94.2% of infants in cohort 2 had been introduced to peanuts, 99.3% to eggs, and 98.6% to cow's milk in infant formula or dairy foods.
One-year assessment of food allergen sensitization and food allergy found the combined prevalence of IgE-mediated peanut, egg, and cow's milk allergies was just 4.1% in cohort 2 vs 12.6% in cohort 1 (adjusted odds ratio [aOR], 0.28; 95% CI, 0.16-0.48; P < .001).
By individual allergy prevalence, peanut was 1.1% vs 5.8% (aOR, 0.24; 95% CI, 0.08-0.76; P = .015), egg was 2.8% vs 11.7% (aOR, 0.23; 95% CI, 0.12-0.45; P < .001), and cow's milk was 0.5% vs 2.4% (aOR, 0.14; 95% CI, 0.04-0.55; P = .005), respectively, in cohort 2 vs cohort 1.
'The marked improvement appeared to result from the direct provision of clear explanations and written copies of the updated feeding guidelines to parents at the time of solid food introduction, especially when compared with the earlier cohort that received no such advice,' Walker said.
'Given that a previous retrospective study in Australia found no reduction in peanut allergy following the updated guidelines, we believe that direct explanation and timely provision of these guidelines to families — specifically around the time of solid food introduction — is critical,' she added. 'This proactive approach appears to be key in encouraging earlier introduction of allergenic foods and achieving the observed reduction in food allergy incidence.'
Because the cohorts included families with existing allergies, some parents were understandably anxious about introducing allergenic foods to their infants, Walker said. 'However, targeted education from our research nurses, along with clear reinforcement that the updated guidelines applied to all infants — regardless of allergy risk — helped alleviate those concerns.' The program received positive feedback from parents, who felt well supported and free to ask questions throughout the process.
Walker noted, however, that the Perth study did not capture data on the frequencies or amounts of consumption of food allergens, although tolerance may also depend on the frequency of consumption and amounts eaten regularly. 'There is still a gap in knowledge surrounding these variables, and we recommend that this data be regularly captured in future prospective studies.'
Offering a US perspective on the study, John M. Kelso, MD, an allergist/immunologist at the Scripps Clinic in San Diego, noted that previous advice on delaying potentially allergenic foods in hopes of preventing food allergies, 'though not illogical, was not evidence-based. It turns out to have been not only unhelpful but rather harmful, instead leading to an increase in food allergy,' he told Medscape Medical News.
He noted that the landmark LEAP trial, published 10 years ago, clearly demonstrated that the early introduction of peanut protein in infancy dramatically decreases the likelihood of peanut allergy, and similar data have emerged for other foods. 'Since then, allergists and pediatricians have routinely recommended that these potentially allergenic foods be introduced into the diet of infants — in any form that does not present a choking hazard — as soon as the infant is developmentally able to ingest solid food at around 4-6 months of age.'
Kelso added that the Australian paper clearly demonstrates that directly providing parents with the updated recommendations is key to a significant reduction in the development of food allergy.
According to the authors, theirs is the first study to demonstrate the effectiveness of direct, proactive provision and implementation of updated infant feeding guidelines to reduce multiple IgE-mediated food allergies.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
'Invariably fatal' rare bat virus claims another victim
A man has died after contracting an extremely rare, rabies-like bat virus, the fourth death since its discovery almost 30 years ago. NSW Health confirmed the man in his 50s died on Thursday after being bitten by a bat several months ago. The northern NSW man was the first recorded case of Australian bat lyssavirus in the state and only the fourth in the nation. Lyssavirus transmits from infected bats to humans when virus in their saliva enters the body through a bite or scratch. Emerging bat viruses expert Alison Peel told AAP the virus, like rabies, travels through the nervous system to the brain. "That happens very slowly so it's quite usual for that to take a number of months between the exposure and the clinical signs developing," the University of Sydney Horizon Fellow said. More than 100 people received medical treatment after potential or suspected exposures each year, Dr Peel said, but it was unknown how many actually contracted the virus. "But certainly, once clinical signs develop ... it's generally, invariably fatal." Australia is home to more than 80 species of bats, and without widespread surveillance of them all, it's safest to assume any bat could be carrying the virus. It was only transmitted through direct contact, so being near bats, or even pooed on by one, was not cause for too much alarm, Dr Peel said. "It's an important consideration to try and avoid direct contact and not touching bats, but we shouldn't panic and take it out on the bats themselves." The virus is also potentially deadly to bats. "It does seem to be circulating within their populations at very, very low levels," Dr Peel said. "But there are quite a high proportion of bats out there that have antibody evidence that suggests that they have been exposed to the virus in the past and they've not become sick. "There is something unique about the way bats are able to handle the infection." It is extremely rare for the virus to transmit to humans because it does not spread through the air. A NSW Health spokesman said anyone bitten or scratched by a bat should seek urgent medical assessment. "Only wildlife handlers who are trained, protected, and vaccinated should interact with bats." People bitten or scratched by a bat require rabies immunoglobulin and rabies vaccine. In 2024, 118 people were treated after being bitten or scratched by a bat around the nation. The virus was first discovered in a black flying fox in Queensland in 1996.
Yahoo
2 hours ago
- Yahoo
AI gives birth to fresh hope against male infertility
Artificial intelligence could make all the difference for would-be parents undergoing IVF and who are struggling with the most severe forms of male infertility. The first Australian study of new technology has led to one live birth and five pregnancies in 12 months among 35 couples who would previously be considered infertile. "These are the most difficult cases that we see at an IVF clinic, so it's very motivating to be able to help people that in a normal world, naturally would never ever be able to have their own children," IVF Australia embryologist Dale Goss told AAP. "It's great to see translation from a science project, essentially a few years ago, and a proof of concept into something that's delivered in the clinic and actually see a healthy baby boy born." The NeoGenix Biosciences employee presented the findings from the first AI SpermSearch clinical study to the European Society of Human Reproduction and Embryology conference in Paris overnight. The system works by searching for the best sperm in semen samples taken from biopsies, offering embryologists another tool to select the most appropriate sperm to be used in IVF. Mr Goss said embryologists could often spend up to six hours looking for enough of the right tiny swimmers but the technology was shown to reduce search times by 75 per cent. "We found that our reducing the time to search, we were able to get through more samples, find more sperm and give these patients a better chance at having their own biological children," he said. The technology was given early access approval for research purposes at Sydney-based Virtus Health but Mr Goss hopes it could be approved for wider use across Australia by the end of the year. About 16 per cent of couples struggle with fertility, according to Family Planning NSW, while 1 in 18 babies in Australia are born through IVF each year. NSW couple Marcela and Rowan Moon experienced infertility until tests confirmed Mr Moon's semen had no sperm because of a genetic condition. "When they told us that Rowan was infertile, I thought 'oh my God I can't have a child with Rowan being the father biologically' and then they said 'no, it's not like that, we can still do it'," Ms Moon said. Mr Moon had a biopsy as a day procedure and doctors took a sample, which was then used to create embryos. The first transfer was hailed a success and the couple later welcomed son Leo. "We were so lucky to get Leo first off the bat ... I don't think we really realised the rollercoaster that it was going to be," Mr Moon said.
Yahoo
3 hours ago
- Yahoo
Too much vitamin B6 can be toxic. 3 symptoms to watch out for
Side effects from taking too much vitamin B6 – including nerve damage – may be more widespread than we think, Australia's medicines regulator says. In an ABC report earlier this week, a spokesperson for the Therapeutic Goods Administration (TGA) says it may have underestimated the extent of the side effects from vitamin B6 supplements. However, there are proposals to limit sales of high-dose versions due to safety concerns. A pathologist who runs a clinic that tests vitamin B6 in blood samples from across Australia also appeared on the program. He told the ABC that data from May suggests 4.5% of samples tested had returned results 'very likely' indicating nerve damage. So what are vitamin B6 supplements? How can they be toxic? And which symptoms do you need to watch out for? Vitamin B6, also known as pyridoxine, plays an important role in keeping the body healthy. It is involved in the metabolism of proteins, carbohydrates and fats in food. It is also important for the production of neurotransmitters – chemical messengers in the brain that maintain its function and regulate your mood. Vitamin B6 also supports the immune system by helping to make antibodies, which fight off infections. And it is needed to produce haemoglobin, the protein in red blood cells that carries oxygen around the body. Some women take a vitamin B6 supplement when pregnant. It is thought this helps reduce the nausea associated with the early stages of pregnancy. Some women also take it to help with premenstrual syndrome. However, most people don't need, and won't benefit from, a vitamin B6 supplement. That's because you get enough vitamin B6 from your diet through meat, breakfast cereal, fruit and vegetables. You don't need much. A dose of 1.3–1.7 milligrams a day is enough for most adults. Currently, vitamin B6 supplements with a daily dose of 5–200mg can be sold over the counter at health food stores, supermarkets and pharmacies. Because of safety concerns, the TGA is proposing limiting their sale to pharmacies, and only after consultation with a pharmacist. Daily doses higher than 200mg already need a doctor's prescription. So under the proposal that would stay the same. If you take too much vitamin B6, in most cases the excess will be excreted in your urine and most people won't experience side effects. But there is a growing concern about long-time, high-dose use. A side effect the medical community is worried about is peripheral neuropathy – where there is damage to the nerves outside the brain and spinal cord. This results in pain, numbness or weakness, usually in your hands and feet. We don't yet know exactly how this happens. In most reported cases, these symptoms disappear once you stop taking the supplement. But for some people it may take three months to two years before they feel completely better. There is growing, but sometimes contradictory, evidence that high doses (more than 50mg a day) for extended periods can result in serious side effects. A study from the 1990s followed 70 patients for five years who took a dose of 100 to 150mg a day. There were no reported cases of neuropathy. But more recent studies show high rates of side effects. A 2023 case report provides details of a man who was taking multiple supplements. This resulted in a daily combined 95mg dose of vitamin B6, and he experienced neuropathy. Another report describes seven cases of neuropathy linked to drinking energy drinks containing vitamin B6. Reports to the TGA's database of adverse events notifications (a record of reported side effects) shows 174 cases of neuropathy linked with vitamin B6 use since 2023. The current advice is that someone who takes a dose of 50mg a day or more, for more than six months, should be monitored by a health-care professional. So if you regularly take vitamin B6 supplements you should discuss continued use with your doctor or pharmacist. There are three side effects to watch out for, the first two related to neuropathy: numbness or pain in the feet and hands difficulty with balance and coordination as a result of muscle weakness heartburn and nausea. If you have worrying side effects after taking vitamin B6 supplements, contact your state's poison information centre on 13 11 26 for advice. This article is republished from The Conversation. It was written by: Nial Wheate, Macquarie University and Slade Matthews, University of Sydney Read more: Does eating cheese before bed really give you nightmares? Here's what the science says How should I talk to my kids about abuse and body safety? Lung cancer screening hopes to save lives. But we also need to watch for possible harms Nial Wheate in the past has received funding from the ACT Cancer Council, Tenovus Scotland, Medical Research Scotland, Scottish Crucible, and the Scottish Universities Life Sciences Alliance. He is a fellow of the Royal Australian Chemical Institute. Nial is the chief scientific officer of Vaihea Skincare LLC, a director of SetDose Pty Ltd (a medical device company) and was previously a Standards Australia panel member for sunscreen agents. He is a member of the Haleon Australia Pty Ltd Pain Advisory Board. Nial regularly consults to industry on issues to do with medicine risk assessments, manufacturing, design and testing. Slade Matthews provides scientific evaluations to the Therapeutic Goods Administration as a member of the Therapeutic Goods Assessment and Advisory Panel. Slade serves on the NSW Poisons Advisory Committee for NSW Health as the minister-nominated pharmacologist appointed by the Governor of NSW.